Hussman Strategic Advisors, Inc. holds a diversified book of 231 stocks worth $434.0M as of Q2 2026 (disclosed Aug 3, 2026, a ~34-day 13F lag). This quarter they opened Teradata Corp and trimmed Viasat Inc. Their largest long position is Pepsico Inc at 1% of the equity book. Cloning the disclosed picks since 2025 would be +13% (+17.9%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1179475/holdings"
Use Arkolith to show HUSSMAN STRATEGIC ADVISORS, INC.'s latest holdings, largest changes, and filing provenance.
Growth of $10,000 cloning Hussman Strategic Advisors, Inc.'s disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~34 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
99% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Pepsico Inc COM | $5.1M | 37.8K | 1.2% | ▲+260% Added · +27K sh | |
| 2 | Ubiquiti Inc COM | $5.0M | 9.4K | 1.2% | ▲+125% Added · +5K sh | |
| 3 | Incyte Corp COM | $4.8M | 42.0K | 1.1% | ▲+33% Added · +11K sh | |
| 4 | Viasat Inc COM | $4.7M | 52.5K | 1.1% | ▼−29% Reduced · −21K sh | |
| 5 | Neurocrine Biosciences Inc COM | $4.6M | 27.3K | 1.1% | ▲+30% Added · +6K sh | |
| 6 | Biogen Inc COM | $4.5M | 21.0K | 1.0% | ▲+233% Added · +15K sh | |
| 7 | Hershey Co COM | $4.4M | 25.2K | 1.0% | ▲+200% Added · +17K sh | |
| 8 | Cimpress PLC SHS EURO | $4.3M | 42.0K | 1.0% | ▲+100% Added · +21K sh | |
| 9 | Ziff Davis Inc COM | $3.8M | 73.5K | 0.9% | ▲+40% Added · +21K sh | |
| 10 | United Nat Foods Inc COM | $3.8M | 84.0K | 0.9% | ▼−20% Reduced · −21K sh | |
| 11 | Ulta Beauty Inc COM | $3.8M | 8.4K | 0.9% | ▲+14% Added · +1K sh | |
| 12 | The Campbells Company COM | $3.7M | 168.0K | 0.9% | ▼−20% Reduced · −42K sh | |
| 13 | General Mills Inc COM | $3.7M | 105.0K | 0.8% | ▲+67% Added · +42K sh | |
| 14 | Teradata Corp Del COM | $3.6M | 105.0K | 0.8% | ▲New New position | |
| 15 | Dollar Gen Corp COM | $3.6M | 31.5K | 0.8% | —Held | |
| 16 | American Eagle Outfitters In COM | $3.6M | 210.0K | 0.8% | —Held | |
| 17 | Pacs Group Inc COM SHS | $3.6M | 84.0K | 0.8% | ▲New New position | |
| 18 | Aurinia Pharmaceuticals Inc COM | $3.6M | 210.0K | 0.8% | ▲+150% Added · +126K sh | |
| 19 | Madden Steven Ltd COM | $3.5M | 84.0K | 0.8% | —Held | |
| 20 | Provident Finl Svcs Inc COM | $3.5M | 147.0K | 0.8% | ▲New New position | |
| 21 | Proto Labs Inc COM | $3.4M | 42.0K | 0.8% | ▼−20% Reduced · −11K sh | |
| 22 | Apa Corporation COM | $3.4M | 105.0K | 0.8% | —Held | |
| 23 | Newmont Corp COM | $3.4M | 36.6K | 0.8% | ▲+200% Added · +24K sh | |
| 24 | Barrick MNG Corp COM SHS | $3.4M | 91.5K | 0.8% | ▲+200% Added · +61K sh | |
| 25 | Mercury Genl Corp New COM | $3.4M | 31.5K | 0.8% | ▲+50% Added · +11K sh | |
| 26 | Medpace Hldgs Inc COM | $3.3M | 6.3K | 0.8% | —Held | |
| 27 | Tootsie Roll Inds Inc COM | $3.3M | 84.0K | 0.8% | ▲+29% Added · +19K sh | |
| 28 | Globus Med Inc CL A | $3.3M | 42.0K | 0.8% | ▲New New position | |
| 29 | Salesforce Inc COM | $3.3M | 21.0K | 0.8% | ▲New New position | |
| 30 | Halozyme Therapeutics Inc COM | $3.3M | 42.0K | 0.8% | ▼−20% Reduced · −11K sh | |
| 31 | Bank Ozk Little Rock Ark COM | $3.3M | 63.0K | 0.8% | ▲New New position | |
| 32 | Regeneron Pharmaceuticals COM | $3.3M | 5.3K | 0.8% | ▲New New position | |
| 33 | Match Group Inc New COM | $3.2M | 84.0K | 0.7% | ▲+33% Added · +21K sh | |
| 34 | Etsy Inc COM | $3.2M | 42.0K | 0.7% | ▼−50% Reduced · −42K sh | |
| 35 | Visteon Corp COM NEW | $3.1M | 31.5K | 0.7% | —Held | |
| 36 | Yeti Hldgs Inc COM | $3.1M | 63.0K | 0.7% | —Held | |
| 37 | Healthcare Svcs Group Inc COM | $3.1M | 126.0K | 0.7% | ▼−25% Reduced · −42K sh | |
| 38 | Amgen Inc COM | $3.0M | 8.4K | 0.7% | ▲+60% Added · +3K sh | |
| 39 | Nextpower Inc CLASS A COM | $3.0M | 25.2K | 0.7% | ▲+50% Added · +8K sh | |
| 40 | Alphabet Inc CAP STK CL A | $3.0M | 8.4K | 0.7% | ▲New New position | |
| 41 | T1 Energy Inc COM NEW | $3.0M | 315.0K | 0.7% | ▲New New position | |
| 42 | Inhibrx Biosciences Inc COM | $3.0M | 31.5K | 0.7% | ▲New New position | |
| 43 | Akamai Technologies Inc COM | $3.0M | 25.2K | 0.7% | ▲+140% Added · +15K sh | |
| 44 | Urban Outfitters Inc COM | $3.0M | 42.0K | 0.7% | —Held | |
| 45 | Macys Inc COM | $3.0M | 126.0K | 0.7% | ▲+20% Added · +21K sh | |
| 46 | Bread Financial Holdings Inc COM | $3.0M | 27.3K | 0.7% | ▼−13% Reduced · −4K sh | |
| 47 | Ameresco Inc CL A | $2.9M | 105.0K | 0.7% | ▼−17% Reduced · −21K sh | |
| 48 | TG Therapeutics Inc COM | $2.9M | 52.5K | 0.7% | ▲New New position | |
| 49 | Agnico Eagle Mines Ltd COM | $2.8M | 18.3K | 0.7% | ▲+200% Added · +12K sh | |
| 50 | Lear Corp COM NEW | $2.8M | 21.0K | 0.6% | ▲+100% Added · +11K sh |
As-of date vs the date the SEC received each filing
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.